Analysis of the MAVIDOS trial - Author's reply

Affiliations

¹ Medical Research Council Lifecourse Epidemiology Unit, University of Southampton, Southampton SO16 6YD, UK; NIHR Southampton Biomedical Research Centre, University of Southampton and University Hospital Southampton NHS Foundation Trust, Southampton, UK.
² Medical Research Council Lifecourse Epidemiology Unit, University of Southampton, Southampton SO16 6YD, UK; Paediatric Endocrinology, University Hospital Southampton NHS Foundation Trust, Southampton, UK.
³ Medical Research Council Lifecourse Epidemiology Unit, University of Southampton, Southampton SO16 6YD, UK; NIHR Southampton Biomedical Research Centre, University of Southampton and University Hospital Southampton NHS Foundation Trust, Southampton, UK; NIHR Musculoskeletal Biomedical Research Unit, University of Oxford, Oxford, UK. Electronic address: cc@mrc.soton.ac.uk.

Comment

Nicholas C Harvey et al. Lancet Diabetes Endocrinol. 2017 May.

. 2017 May;5(5):328-329.

doi: 10.1016/S2213-8587(17)30113-4.

¹ Medical Research Council Lifecourse Epidemiology Unit, University of Southampton, Southampton SO16 6YD, UK; NIHR Southampton Biomedical Research Centre, University of Southampton and University Hospital Southampton NHS Foundation Trust, Southampton, UK.
² Medical Research Council Lifecourse Epidemiology Unit, University of Southampton, Southampton SO16 6YD, UK; Paediatric Endocrinology, University Hospital Southampton NHS Foundation Trust, Southampton, UK.
³ Medical Research Council Lifecourse Epidemiology Unit, University of Southampton, Southampton SO16 6YD, UK; NIHR Southampton Biomedical Research Centre, University of Southampton and University Hospital Southampton NHS Foundation Trust, Southampton, UK; NIHR Musculoskeletal Biomedical Research Unit, University of Oxford, Oxford, UK. Electronic address: cc@mrc.soton.ac.uk.

No abstract available

Comment on

Maternal gestational vitamin D supplementation and offspring bone health (MAVIDOS): a multicentre, double-blind, randomised placebo-controlled trial.
Cooper C, Harvey NC, Bishop NJ, Kennedy S, Papageorghiou AT, Schoenmakers I, Fraser R, Gandhi SV, Carr A, D'Angelo S, Crozier SR, Moon RJ, Arden NK, Dennison EM, Godfrey KM, Inskip HM, Prentice A, Mughal MZ, Eastell R, Reid DM, Javaid MK; MAVIDOS Study Group. Cooper C, et al. Lancet Diabetes Endocrinol. 2016 May;4(5):393-402. doi: 10.1016/S2213-8587(16)00044-9. Epub 2016 Mar 2. Lancet Diabetes Endocrinol. 2016. PMID: 26944421 Free PMC article. Clinical Trial.
Analysis of the MAVIDOS trial.
Kovacs CS. Kovacs CS. Lancet Diabetes Endocrinol. 2017 May;5(5):328. doi: 10.1016/S2213-8587(17)30114-6. Lancet Diabetes Endocrinol. 2017. PMID: 28434489 No abstract available.

1. Cooper C, Harvey NC, Bishop NJ, et al. Maternal gestational vitamin D supplementation and offspring bone health (MAVIDOS): a multicentre, double-blind, randomised placebo-controlled trial. The Lancet Diabetes & Endocrinology. 2016;4(5):393–402. - PMC - PubMed
1. Harvey NC, Javaid K, Bishop N, et al. MAVIDOS Maternal Vitamin D Osteoporosis Study: study protocol for a randomized controlled trial. Trials. 2012;13(1):13. - PMC - PubMed
1. Kovacs CS. Does fetal exposure to vitamin D programme childhood bone mass? The Lancet Diabetes & Endocrinology. 2017 - PubMed
1. Crabtree NJ, Arabi A, Bachrach LK, et al. Dual-energy X-ray absorptiometry interpretation and reporting in children and adolescents: the revised 2013 ISCD Pediatric Official Positions. J Clin Densitom. 2014;17(2):225–42. - PubMed
1. Baird J, Barker M, Harvey NC, et al. Southampton PRegnancy Intervention for the Next Generation (SPRING): protocol for a randomised controlled trial. Trials. 2016;17(1):493. - PMC - PubMed